Assignee
CUREGENIX INC
CN·7 granted patents·3 pending applications·16 citations·filing 2014–2022
Top patents by PatentIndex Score
10 records- 0184US10238652B2Compounds for treatment of cancerCUREGENIX INC·Filed 2017·Granted Mar 26, 2019·4 cites·17 claims
- 0281US9713612B2Compounds for treatment of cancerCUREGENIX INC·Filed 2014·Granted Jul 25, 2017·5 cites·36 claims
- 0379US9744169B2Compounds for treatment of fibrosis diseasesCUREGENIX INC·Filed 2014·Granted Aug 29, 2017·4 cites·28 claims
- 0476US10087181B2Compound as WNT signaling inhibitor, composition, and use thereofCUREGENIX INC·Filed 2016·Granted Oct 2, 2018·2 cites·11 claims
- 0574US10285988B2Compounds for treatment of fibrosis diseasesCUREGENIX INC·Filed 2017·Granted May 14, 2019·1 cites·18 claims
- 0670US10660889B2Compounds for treatment of cancerCUREGENIX INC·Filed 2019·Granted May 26, 2020·0 cites·11 claims
- 0767US2023201194A1Combination compositions for immunotherapyCUREGENIX INC·Filed 2022·Application pending·0 cites
- 0856US2019209558A1Compounds for treatment of fibrosis diseasesCUREGENIX INC·Filed 2019·Application pending·0 cites
- 0939US10702473B2Liposome formulation for delivery of Wnt signal pathway inhibitorCUREGENIX INC·Filed 2018·Granted Jul 7, 2020·0 cites·7 claims
- 1039US2019022002A1Liposome formulation for delivery of wnt signal pathway inhibitor and a method for preparing the sameCUREGENIX INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when CUREGENIX INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →